Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology
Top Cited Papers
- 4 November 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 20 (6), 692-699
- https://doi.org/10.1016/j.copbio.2009.10.010
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Abatacept, a Novel CD80/86–CD28 T Cell Co‐stimulation Modulator, in the Treatment of Rheumatoid ArthritisBasic & Clinical Pharmacology & Toxicology, 2009
- RomiplostimDrugs, 2009
- Molecular decoys: antidotes, therapeutics and immunomodulatorsCurrent Opinion in Biotechnology, 2008
- Discovering and improving novel peptide therapeuticsCurrent Opinion in Pharmacology, 2008
- The TNF Superfamily-2008Cytokine & Growth Factor Reviews, 2008
- Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose HomeostasisDiabetes, 2008
- Immunoglobulin superfamily cell adhesion molecules: zippers and signalsCurrent Opinion in Cell Biology, 2007
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- ImmunoadhesinsInternational Reviews of Immunology, 1993